Publication | Closed Access

Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine

VaccinationVaccine SafetyVaccinologyVaccine DevelopmentMedicineImmunologyVaccine TestingVaricella VaccineMonths–2 YearsVaccine HesitancyPrecision VaccinologyVaccine Research